SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

AdaptHealth Corp. (AHCO) News

Follow AdaptHealth Corp. (AHCO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 18 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol AHCO Asset equity Sector Markets 90 days 6 Last 6.27 Updated Sep 08, 2026, 08:25 PM UTC Open live news feed Open AHCO chart & news
M AdaptHealth Swings to Q3 Loss as Revenue Rises, Raises 2026 Revenue Guidance AdaptHealth reported a Q3 loss, while revenue rose. The company raised its 2026 revenue guidance. EQUITY | Nov 03, 2026, 02:08 PM UTC M AdaptHealth Reports Q3 Revenue Growth and $154 Million Net Loss AdaptHealth reported third-quarter 2026 revenue of $745.6 million, up 10.9% year over year. Attributable net loss was $154.0 million, including a $184.8 million goodwill impairment charge; adjusted EBITDA was $141.9 mill EQUITY | Nov 03, 2026, 01:22 PM UTC M AdaptHealth Expects 2026 Revenue of $2.88B-$2.90B AdaptHealth expects full-year 2026 revenue of $2.88 billion to $2.90 billion, versus a FactSet estimate of $2.88 billion. EARNINGS | Nov 03, 2026, 12:32 PM UTC M AdaptHealth Q3 Revenue Comes in at $745.648 Million AdaptHealth reported Q3 revenue of $745.648 million, versus an IBES estimate of $746.4 million. EQUITY | Nov 03, 2026, 12:32 PM UTC M AdaptHealth Posts Q3 Loss on Goodwill Impairment Charge AdaptHealth reported a third-quarter loss, attributing it to a goodwill impairment charge. EQUITY | Nov 03, 2026, 12:21 PM UTC M AdaptHealth Sets FY Adjusted EBITDA Outlook at $510–525 Million EARNINGS | Nov 03, 2026, 12:07 PM UTC M AdaptHealth Swings to Q3 Net Loss of $168.2 Million Q3 net revenue rose 11% to $745.6 million. EQUITY | Nov 03, 2026, 12:07 PM UTC M AdaptHealth Issues FY Revenue Outlook AdaptHealth's FY revenue outlook is provided in the source. EARNINGS | Nov 03, 2026, 12:07 PM UTC M AdaptHealth announces third-quarter 2026 results EQUITY | Nov 03, 2026, 12:01 PM UTC L Adapt appoints Harriss Currie as CFO, announces departure Adapt appointed Harriss Currie as chief financial officer effective September 9, 2026, and said CFO Jason Clemens will depart effective October 1, 2026; his authority ends September 8. REGULATION | Sep 08, 2026, 08:25 PM UTC L AdaptHealth appoints Harriss Currie as Chief Financial Officer AdaptHealth has appointed Harriss Currie as Chief Financial Officer, according to a company release. EQUITY | Sep 08, 2026, 08:03 PM UTC L AdaptHealth names Harriss T. Currie as CFO AdaptHealth Corp. says its Board of Directors named Harriss T. Currie as Chief Financial Officer. EQUITY | Sep 08, 2026, 08:00 PM UTC L AdaptHealth appoints Harriss Currie as CFO AdaptHealth appoints Harriss Currie as Chief Financial Officer. EQUITY | Sep 08, 2026, 08:00 PM UTC L AHCO - ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health AHCO - ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health EQUITY | Aug 17, 2026, 01:01 PM UTC M Insiders Buy AHCO, BXSY, CLVT Stocks Directors and owners purchase company shares EQUITY | Aug 11, 2026, 09:30 AM UTC H Crude Oil Down Over 5%; McDonald's Earnings Top Views U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 2% on Tuesday. The Dow traded up 1.79% to 54,129.35 while the NASDAQ rose 2.22% to 26,490.24. The S&P 500 also rose, gaining, 1.64% EARNINGS | Aug 04, 2026, 04:55 PM UTC L AHCO - AdaptHealth Corp. Announces Second Quarter 2026 Results AHCO - AdaptHealth Corp. Announces Second Quarter 2026 Results EARNINGS | Aug 04, 2026, 11:06 AM UTC L AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est AdaptHealth (NASDAQ: AHCO ) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 billion-$2.890 billion vs $3.488 billion estimate. EARNINGS | Aug 04, 2026, 11:03 AM UTC L AHCO upgraded from Hold to Buy W/ $13 PT (from $11) @ JEFF AHCO upgraded from Hold to Buy W/ $13 PT (from $11) @ JEFF EQUITY | Jul 21, 2026, 12:45 PM UTC L AHCO Upgrade from Hold to Buy W/$13.00 PT (from $11.00) at Jefferies AHCO Upgrade from Hold to Buy W/$13.00 PT (from $11.00) at Jefferies EQUITY | Jul 21, 2026, 12:08 PM UTC L AHCO Adapthealth Corp. enters into definitive agreement to divest Diabetes health business to Cardinal Health Adapthealth Corp - Cardinal He AHCO Adapthealth Corp. enters into definitive agreement to divest Diabetes health business to Cardinal Health Adapthealth Corp - Cardinal Health to buy Diabetes health business for $235M in cash EQUITY | Jul 20, 2026, 08:30 PM UTC L AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems AdaptHealth Corp. (NASDAQ: AHCO ) on Thursday disclosed that it is investigating a cybersecurity incident after a threat actor gained unauthorized access to certain company systems and exfiltrated data. The company class REGULATION | Jul 06, 2026, 02:34 PM UTC L IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo cut the price targ EQUITY | Jul 06, 2026, 12:21 PM UTC L 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Seer (NASDAQ: SEER ) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ: UPC ) stock m EQUITY | Jul 02, 2026, 09:05 PM UTC L AdaptHealth Reports Material Cybersecurity Incident () -- AdaptHealth (AHCO) said Thursday it is investigating a material cybersecurity incident in which a threat actor gained unauthorized access to company systems and exfiltrated certain data. The company said it determi EQUITY | Jul 02, 2026, 09:01 PM UTC L AdaptHealth shares are trading lower after the company disclosed an investigation into a security incident where a threat actor gained autho AdaptHealth shares are trading lower after the company disclosed an investigation into a security incident where a threat actor gained authorized access to systems and exfiltrated certain data. EQUITY | Jul 02, 2026, 08:24 PM UTC L AdaptHealth Discloses Investigation Into Security Incident Where Threat Actor Gained Authorized Access To Systems And Exfiltrated Certain Da SEC Filing REGULATION | Jul 02, 2026, 08:06 PM UTC